Efficacy of Ulinastatin for Reducing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients

NCT03387774 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

179

Enrollment

OTHER

Sponsor class

Conditions

Oral Mucositis (Ulcerative) Due to Radiation

Interventions

DRUG: Cisplatin
RADIATION: Intensity Modulated Radiation Therapy
DRUG: Ulinastatin

Sponsor

Sun Yat-sen University

Collaborators

[object Object]
[object Object]
[object Object]